CMND — Clearmind Medicine Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapSucker Stock
- CA$4.25m
- -CA$0.40m
Annual cashflow statement for Clearmind Medicine, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | R2021 October 31st | 2022 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.195 | -0.105 | -0.233 | -3.72 | -9.41 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.087 | 0 | — | 0.856 | 2.53 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.002 | 0.042 | -0.031 | 0.026 | 1.69 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.106 | -0.063 | -0.264 | -2.84 | -5.08 |
| Capital Expenditures | -0.131 | -0.01 | -0.01 | -0.033 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.005 | -0.218 | 0 |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.131 | -0.01 | -0.005 | -0.251 | -0.008 |
| Financing Cash Flow Items | -0.002 | 0 | -0.051 | 0 | -0.02 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.208 | 0 | 0.599 | 7.36 | 0.698 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.029 | -0.073 | 0.329 | 4.27 | -4.42 |